(Reuters) - Baxter International Inc said on Thursday that it would spin off its biotechnology operations into a publicly traded company by the middle of next year and focus on its core medical technology business, sending its shares up more than 7 percent.
via Reuters: Health News Read More Here..
No comments:
Post a Comment